We’ve developed a portfolio of multiplexed, multi-omic technologies to help you decode the immune response to infectious diseases, including SARS-CoV-2.
ChipCytometry is a high-plex, quantitative imaging platform with single cell resolution. Quickly identify and visualize immune cell populations and subpopulations, and gate cells using flow cytometry-like data analyses.
NEW! COVID-19 Panel Now Available.
The rise of new pathogens such as SARS-CoV-2 has brought to light how important infectious disease research is. NanoString's nCounter technology efficiently enables researchers to work on urgent needs for therapeutic and vaccine development as well as a basic understanding of the virus. The newly launched COVID-19 probe set has 10 genes, 8 of which are COVID-19 viral protein genes, and is ideal to pair with any of the immunology gene expression panels.
Canopy Biosciences is the first NanoString core to offer the new COVID-19 NanoString probe set.
RNA-Seq allows for the rapid identification of changes in gene expression across the entire exome. Profile immune disruptions due to the SARs-CoV-2 virus, identify novel biomarkers to aid in infectious disease research and more.